NEWS

Neurinnov announced it has been awarded a €2.5 million grant under the highly selective European Innovation Council (EIC) Accelerator program. This funding may be complemented by a future equity investment by the EIC Fund, subject to due process and company milestones.

The EIC Accelerator support will enable Neurinnov to accelerate the clinical, regulatory, and industrial development of its first-in-class neurostimulation device designed to restore hand function in patients with complete tetraplegia, a population for which no therapeutic solution currently exists. The program will notably support the company’s path toward US and European certification and the launch of its upcoming pivotal clinical trial.

Read our press release here.

Conference and Symposium Nervclub, Heidelberg (Germany)

On January, 30th 2026, David Guiraud from Neurinnov presented the AI-Hand 2023 project at the "Neurosurgery meets Neurotechnology" conference by Department of Neurosurgery Heidelberg. He notably described partners' activities to restore hand functions of patients with spinal cord injury by nerve cuff-electrodes.

David Andreu, Directeur général de Neurinnov et Thomas Guiho, collègue et chercheur à l'INRIA, ont participé à une table ronde du Lab Santé Midi Libre, le 13 novembre 2025.

Ils ont notamment évoqué le projet de recherche AI-Hand qui vise à aider des personnes tétraplégiques à retrouver l'usage d'une main et donc de l'autonomie.

Lire l'article.

Visionner la table ronde.

2024 - Neurinnov announces that it has been selected as a laureate of Boost Invest MedVallée Montpellier by its expert committee, receiving the special “Waouh” award. This distinction recognises breakthrough innovation with high potential. MedVallée is a true accelerator for global health innovation, bringing together talent, expertise, and vision to address tomorrow’s major challenges. Neurinnov is honoured to join this ambitious initiative, aimed at boosting the growth of innovative companies on a national and international scale.

The press talks about Neurinnov: Hérault Tribune, Actu.fr, Ecom News 

2023 - Neurinnov announces its participation in the DREIMS European project under the HORIZON EIC-2023-TRANSITION programme. The project will last for 36 months and aims to design and develop a multi-contact neural stimulator based on the company’s selective neural stimulation technology to treat spinal cord injuries. The project will combine biomaterials, pharmaceuticals, and electrical stimulation to create an innovative therapeutic solution capable of promoting spinal cord gap closure, axonal regrowth, and glial cell migration across large lesions in rodent and porcine models of spinal cord injury.

For more information, visit the DREIMS website at: http://www.dreims-project.eu

2023 - Neurinnov announces its involvement in the AI-Hand Project, launched on November 28th. This EU-funded project, under the HORIZON-EIC-2022-PATHFINDEROPEN-01 programme, will run for 42 months and aims to restore hand functions in patients with low tetraplegia through selective neural electrical stimulation. Neurinnov is committed to the success of the AI-HAND project, working with its partners to bring this solution to patients. Learn more about this projet.

  Neurinnov announces that it has been awarded the €30K Grand Prize in the “Products or Services for the Future” category at the Les Inn’Ovations awards, organised by @AD'OCC. The company’s implantable neurostimulator, which enables patients with complete tetraplegia to regain upper limb autonomy, impressed the jury. This active implantable medical device, powered by Neurinnov’s patented remotely controlled ASIC chip, helps restore hand function for spinal cord injury patients, allowing them to perform daily tasks such as eating with a fork or drinking through a straw, and ultimately providing them with greater independence.

Every year, the Les Inn’Ovations awards recognise some of the most innovative projects in the Occitania region of France.

Neurinnov announces it has published positive results from its clinical studies on restoring hand control in patients with high spinal cord injuries. These results were published in Nature Scientific Reports and Neurotrauma, in collaboration with INRIA CAMIN, Centre Bouffard-Vercelli USSAP, ORTHOSUD St Jean de Védas, CORTEC and APHP.
Click here to see the Nature Scientific Reports, 2022
Click here to see the video.

Des chercheurs et ingénieurs de l'Inria, associés à la société Neurinnov et des établissements de santé en Occitanie, ont mis au point un dispositif médical capable de restaurer, partiellement, les mouvements de la main chez des patients souffrant d'une paralysie des avant-bras. Les premiers résultats cliniques sont validés par une publication scientifique.